None listed
Conditions
Interventions
Drug : Patients with periampullary tumors scheduled for pancreaticoduodenectomy were randomly assigned to either the preoperative ferritin administration group (Group A) or the placebo group (Group B)
Sponsors
The Catholic University of Korea, Seoul St. Mary's Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: ? For patients with periampullary tumors for whom pancreaticoduodenectomy is planned ? Under 75 years old
Exclusion criteria
Exclusion criteria: ? Disease relief or emergency surgery ? Incurable or metastatic disease state ? Insufficient data ? Accompanied by hematological disorders that can cause anemia ? Follow-up observation failure ? Contraindications to intravenous ferritin administration (pregnancy or lactation, age under 18, history of severe asthma or infection, chronic renal failure, simultaneous oral and intravenous iron administration, allergic reaction to iron)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in hematological parameters after surgery | — |
Secondary
| Measure | Time frame |
|---|---|
| Postoperative transfusion rate and morbidity | — |
Countries
Korea, Republic of
Contacts
Public ContactSung eun Park
The Catholic University of Korea, Seoul St. Mary's Hospital
Outcome results
None listed